Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 7, 2005
View Archived Issues
TPA blocks growth of pancreatic tumors in mice
Read More
In vitro activity of AMN-107 against imatinib-resistant CML cell lines
Read More
2-Methoxyestradiol shows promise in the management of rheumatoid arthritis
Read More
Epicatechin gallate maintains mitochondrial activity during wound healing
Read More
Antileukinate protects mice against cerulein-induced acute pancreatitis
Read More
Preclinical studies of oglemilast uncover its antiarthritic potential
Read More
Pharming's recombinant human fibrinogen selected for U.S. Army project
Read More
AD-452 enters phase IIb study in rheumatoid arthritis
Read More
TAP terminates license of Flamel technology for delivery of lansoprazole
Read More
Enrollment completed in phase III efficacy study of frovatriptan
Read More
Antisoma reopens phase I study of AS-1411 to renal and lung cancer patients
Read More
Solvay launches Duodopa in 12 new European countries
Read More
Recent patents report novel agents for thrombotic disorders
Read More
Cephalon files NDA for OraVescent fentanyl for breakthrough cancer pain
Read More
Memantine for cocaine and tobacco addiction
Read More
Ambien CR receives FDA approval for the treatment of insomnia
Read More
Labopharm receives European approvals for once-daily tramadol
Read More
Recent Allergan patent reports new treatments for glaucoma
Read More
Patient recruitment for phase I evaluation of N-acetylcysteine in cocaine dependence
Read More
New agents for asthma patented
Read More
Proquad approved to protect children from measles, mumps, rubella & varicella
Read More
ICC-1132 induces immune responses against P. falciparum in healthy volunteers
Read More
New clinical data on ziconotide for the treatment of chronic pain
Read More
Olanzapine reduces nausea and vomiting in patients receiving emetogenic chemotherapy
Read More
New data on the efficacy of aprepitant in the prevention of CINV
Read More
Update on the potential of SVT-40776 as a novel treatment for overactive bladder
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe